Sepsis is one of the leading worldwide causes of morbidity and mortality in critically-ill patients.Prediction of outcome in patients with sepsis requires repea
AIM:To show a new paradigm of simultaneously testing whether breast cancer therapies impact other causes of death.METHODS:MA.14 allocated 667 postmenopausal wom
Erlotinib and gefitinib are among the most widely researched,used and available molecularly targeted therapies for treatment of advanced non-small cell lung can
Acute respiratory distress syndrome(ARDS)represents a serious problem in critically ill patients and is associated with in-hospital mortality rates of 33%-52%.R
Growing evidence suggests that breast cancer cell plasticity arises due to a partial reactivation of epithelialmesenchymal transition(EMT)programs in order to g
Breast cancer(BC)is the most common cancer among women worldwide.The aetiology and carcinogenesis of BC are not clearly defined,although genetic,hormonal,lifest